In the News
How are organizations balancing cost with regulatory, supply chain, and reputational risk when selecting partners or sites?
Myriam Antoun contributes her thoughts about how balance global cost advantages with regulatory, supply chain and reputational risk.
Q&A: Why Sponsors Are Turning to Mixed FSP/FSO Models
Samantha Hadfield, VP, FSP solutions, shares why sponsors are turning to hybrid models.
Vitiligo registry to advance real-world evidence
Dr. Peter Wahl shares about the PPD CorEvitas Vitiligo Registry to generate long-term real-world evidence on nonsegmental vitiligo, including treatment effectiveness and patient experiences, and help address evidence gaps that can inform future research and clinical decision-making.
A practical route through regulatory uncertainty in clinical trials
Myriam Antoun, Lead, FSP Regulatory Affairs, describes how organizations must remain agile across global portfolios and anticipate regulatory changes before they create delays, and how partnering with a FSP is one of the most effective strategies.
Arcturus Picks Thermo Fisher To Support Cystic Fibrosis Therapy
Coverage of Arcturus Therapeutics’ collaboration with Thermo Fisher to support Phase 3 development and potential commercialization of ARCT-032, including clinical research through the PPD business.
Moving from patient centricity to patient partnership
PPD clinical research colleagues Maddie Yorke, Danielle Drachmann and Phil Leventhal examine how deeper patient partnership and co-creation can improve research relevance, trial design and engagement.
Integration: The key to scalable decentralised trials
Richie Pfeiffer, senior director of patient first digital solutions at Thermo Fisher Scientific, discusses why successful decentralized trials depend on integrated operations, technology and patient services.
Accelerating advanced therapies through rapid microbial methods
Katelyn Nelligan discusses how automation can help ensure the safety and efficacy of advanced therapeutic products.
Making the Cold Chain Green: An Interview with Michael J Cohen
Michael J Cohen, Lead Senior Director of Environmental Sustainability at the PPD clinical research business of Thermo Fisher Scientific, talks about tackling waste, improving cold chain operations, and using data to create smarter, more efficient solutions.
